Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
How Sports Stars and Drugs Keep Getting Reinvented
Reinvention is everywhere. Products get updated, industries change course, and ideas we once treated as finished suddenly come back in a new form. Something that felt permanent five years ago can look completely different today, redesigned for a new audience or a new moment. read more
Post-Approval Change Management
Achieving global approval for a single change may take three to five years, but inefficient lifecycle change management rarely registers as a crisis. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Artis BioSolutions Launches Genetic Medicines Center in Spain
Thursday, August 27, 2026
Artis BioSolutions has launched a Genetic Medicines Center of Excellence in Bilbao, Spain, adding mRNA and lipid nanoparticle development and ... read more
4basebio, Genezen Partner on Cell-Free DNA for Viral Vector Manufacturing
Thursday, August 27, 2026
4basebio and Genezen have expanded a non-exclusive collaboration intended to give cell and gene therapy developers access to synthetic, cell-free DNA ... read more
Centrix Pharma, University of Sussex Launch £375,000 Data Science Partnership
Wednesday, August 26, 2026
Centrix Pharma Solutions has partnered with the University of Sussex on a £375,000 Knowledge Transfer Partnership aimed at using data analytics and ... read more
Lonza Names Samanta Cimitan Chief Commercial Officer
Wednesday, August 26, 2026
Lonza has appointed Samanta Cimitan as chief commercial officer, senior vice president and a member of its Extended Executive Committee, creating a ... read more
Symbiosis Appoints Jay Chima as Vice President of Business Development
Wednesday, August 26, 2026
Symbiosis Pharmaceutical Services has appointed Jay Chima as vice president of business development as the aseptic fill-finish contract development ... read more